Riskpilot← Back to searchSign inGet full accessVeinbaum Optik AB
ABActiveOrg 5592177629Odengatan 45Retail sale of medical and orthopaedic goods · NACE 4774Est. 20193 employees
Revenue 2025
SEK 1,9M
+12% vs 2024
EBITDA margin
-3.2%
-263% vs 2024
Equity ratio
14.6%
Financial strength
Net profit 2025
SEK -69K
-339% vs 2024
| Revenue | SEK 1,9M | +12% |
| EBITDA | SEK -61K | -263% |
| Net profit | SEK -69K | -339% |
| Total assets | SEK 586K | -9% |
| Equity | SEK 86K | -45% |
| Employees | 3 | — |
Legal name
Veinbaum Optik AB
Org number
5592177629
Legal form
Aktiebolag
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
9 september 2019
Share capital
SEK 50 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Tillhandahålla tjänster inom optikverksamhet
Address
Odengatan 45
Email
swepierre@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 1 353 | 1 694 | 1 436 | 1 537 | 1 681 | 1 882 |
| Staff expenses | — | — | — | −963 | −1 096 | −1 334 |
| EBITDA | 505 | −182 | −122 | 14 | 37 | −61 |
| Depreciation & amort. | −0 | −10 | −10 | −10 | −10 | −10 |
| EBIT | 505 | −192 | −132 | 4 | 27 | −71 |
| Net financials | — | — | −1 | 0 | 2 | 1 |
| Profit before tax | 504 | −192 | −132 | 4 | 29 | −69 |
| Tax | −108 | −0 | −0 | — | — | — |
| Net profit | 396 | −192 | −132 | 4 | 29 | −69 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 691 | 979 | 626 | 557 | 641 | 586 |
| Equity | 446 | 254 | 122 | 126 | 155 | 86 |
| Long-term debt | 0 | 0 | 252 | 189 | 189 | 189 |
| Short-term debt | 245 | 725 | 252 | 242 | 297 | 311 |
| Total debt | 245 | 725 | 504 | 431 | 486 | 500 |
EBITDA margin
-3.2%
This company
15.8%
Market median
-120% vs market
20202025
Equity ratio
14.6%
This company
38.2%
Market median
-62% vs market
20202025
Return on equity
-81.0%
This company
18.4%
Market median
-540% vs market
20202025
Net profit margin
-3.7%
This company
8.1%
Market median
-146% vs market
20202025
Asset turnover
3.21×
This company
1.12×
Market median
+187% vs market
20202025
Debt / equity
5.83×
This company
0.62×
Market median
-840% vs market
20202025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-06-30
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Veinbaum Optik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| William Gabriel Simon Chamoun | Deputy Board Member | 0 companies |
| Marcelle Chamoun | Deputy Board Member | 0 companies |
| Pierre Chamoun | Board of Directors | 0 companies |
| Christian Pierre Chamoun | Board of Directors | 0 companies |